Try our Advanced Search for more refined results
Life Sciences - February, 2009
143 articles
- Stryker Tries To Quash Antitrust Class Actions
- Amgen, Wyeth To Fight Suit Over Aranesp, Enbrel
- Regulatory Oversight In Health Care
- Mannatech Settles Texas AG Fraud Probe For $6M
- Investors, NPS Pharma Strike $15M Deal In Preos Suit
- Novartis Unit To Appeal $47.1M Contact Lens Ruling
- Vapor Intrusion: New Exposures, Old Sites
- Aurobindo USA Can't Get Out Of Crestor MDL: Judge
- Obama's 2010 Budget Seeks $1B For Food Safety
- FDA Requires Black Box Warning For GI Drug
- Abbott Lied About Rival's Infant Formula: Suit
- Obama Touts Generic Biologics To Lower Drug Costs
- AstraZeneca To Make Seroquel Label Changes
- Novo Seeks To Halt Caraco Launch Of Generic Prandin
- Judge Nixes Expired Product Suit Against Rite Aid
- No New Trial For Applied In Covidien IP Spat: Court
- Tainted Syringes Spark International Manhunt
- AntiCancer Takes New Shot At Rival Over Patents
- MedImmune Keeps Up Fight Against Generic Ethyol
- FDA Says Ranbaxy Falsified Data From India Plant
- Teva Loses Bid To Toss Novartis Claims Over Famvir
- US Unseals FCA Suit Over Lexapro, Celexa
- KV Targets Citigroup Over $72M In Illiquid ARS
- The Scope Of Fraud In Multiclass Registrations
- Judge Strikes J&J Invalidity Contentions In Stent Suit
- Fed. Circ. Affirms Stay Extension In Evista Dispute
- Diagnosing Section 1 Violations
- Eye Surgery Antitrust Suit Against Alcon Dismissed
- PCB Case Against Monsanto Remanded To State Court
- Buyer Class Still Valid In Nifedipine Antitrust Suit
- 1st Circ. Refuses To Rehear Dispute Over Visudyne
- Ala. Jury Hits Sandoz For $78M In Medicaid Fraud Suit
- Ill. AG Sues Caterpillar Over Oil-Waste Spill
- Judge Rejects Interest For Lowey In Bayer Settlement
- Fentora Patent Suit Just A Delay Tactic: Barr
- Adverse Event Reporting To The IRB
- What's Next For Physician-Owned Hospitals?
- Judge Keeps TriCor Competition Suit Alive
- High Court Refusal Lets Lexapro Patent Suit Continue
- C&D, Abbott $29M Pregnancy Test Patent Suit Ended
- Appropriations Bill Calls For $335M Increase To FDA
- Epilepsy Drug Linked To Blood Disorder: FDA
- Allergan Patent For Zymar Not Valid: Apotex
- Ex-Stryker Sales Rep Pleads Guilty To Misbranding
- BMS Settles Container Patent Suit Against Abbott
- Fed. Circ. Takes On Prior Claim Construction Issue
- Judge Tosses Suit V. Funds Over Attorney Conduct
- Fed. Circ. Reopens Enzo DNA Detection Patent Case
- Cardinal Reaches Deal With FDA Over Drug Pumps
- Lawmakers Demand Information On Vytorin Trials
- DOJ Joins Qui Tam Suits Over Off-Label Natrecor Use
- Generic Patent Challenges Up 19% In '08: Report
- Amphastar Antitrust Claims Nixed In Lovenox Suit
- Rescuecom And Keyword Advertising Issues
- Deaths Prompt Warnings On Psoriasis Drug Raptiva
- Endo, Actavis Settle Spat Over Painkiller Patents
- 11 Fla. Cases Settled In Fen-Phen MDL V. Wyeth
- Meth Epidemic: Invitation To Social Engineering
- Medtronic Wins On Preemption In Wis. High Court
- Pfizer Unit May Have To Pay $153M In Fraud Case
- Fictional Characters, Storytelling And Patent Trials
- Advanced Medical Optics Investor Sues Over Merger
- Medtronic Counsel Returns To Oppenheimer Wolff
- Wiley Rein Scores WilmerHale FDA Policy Guru
- Ariad Faces Derivative Suit After Directors Cut Ties
- Tech-Based Venues Pushing Rocket Dockets Aside
- Baxter Wins Round In Dialysis Machine Patent Suit
- 3rd-Party Payers In Guidant Case Seek Appeal
- Acacia Unit, Edwards Settle Catheter Patent Suit
- AAI Protests Pfizer-Wyeth Merger
- Medtronic MDL Judge's Son Linked To Company
- Spain Recalls Gardasil Batch After Illnesses
- Fed. Claims Court Finds No Vaccines-Autism Link
- Judge Accuses Stryker Of Warped Riegel Reading
- Zicam Maker Targeted In IP Suit Over Cold Remedy
- Novartis, Par Settle Patent Suit Over Lotrel
- Bristol-Myers, IBM Agree To $14M Superfund Cleanup
- 7th Circ. Upholds Evidence Limits In Effexor Suit
- CSX Units Must Pay For NJ River Cleanup: 3rd Circ.
- Medical Cos.' Success With Riegel May Be Short-Lived
- Judge OKs Partial Class Status In ERISA Suit V. Merck
- The Modern Reality Of The FCPA
- Fraud Claims Live Against Biovail Execs In SEC Case
- Harry And David Sues Rival Over Keyword Trigger
- Judge Decertifies Class In Off-Label Neurontin Suit
- Protein From Engineered Goats Wins FDA Approval
- Judge Slams Plaintiffs' Experts In Nixing Seroquel Suit
- Fed. Circ. Nixes $2M Ruling V. Bath & Body Works
- FDA Seeks Stronger Safeguards For Addictive Opioids
- King & Spalding Nabs 3 Baker Botts IP Partners
- Globalization Could Incite Global Forum Shopping
- Deferred Prosecution Deals Dip Sharply In 2008
- Pfizer Commits To Physician Payment Disclosures
- Leahy Discloses Plan To Reintroduce Patent Reform
- Medtronic Stent Patent Claims Not Indefinite: Judge
- Berkshire Hathaway Cos. Hit With RICO Suit
- Life Sciences Practice: Reed Smith
- Federal Preemption Shifting, Not Dead: Experts
- 27 State AGs, Bayer Strike Deal Over Yaz Ads
- The Problem With IMS Health V. Ayotte
- Top Motions In An IP Case And How To Win Them
- Alternative Electrodes' Antitrust Claims Kept Alive
- Drug Co. Gets OK To Fight Damages In Seroquel MDL
- Quinn Emanuel Picks Up 3 IP Partners
- 'Ordinary' Skill In The Art After KSR
- Dismissed Medtronic MDL Could Get New Lease On Life
- Obviousness Of Enantiomers After KSR
- PerkinElmer Sues To Nix Down Syndrome Test Patent
- SciCo Fights Boston Scientific Sanctions Bid In IP Suit
- Anticipated Policy Shift For Stem Cell Research
- Securities Suit Against Baxter Gets The Boot
- Cordis Hit With $22M Verdict In Stent Patent Case
- K-Dur Reverse Payment Legal: Special Master
- Top Sens. Target Drug Cos.' Pay-For-Delay Deals
- Injunctions And Medical Devices
- Lawyers Eye Seeds Of Litigation Wave In Layoffs
- 3 Private Actions Fight AndroGel Reverse Payments
- KV Halts Prenatal, Iron Supplements In 4th Recall
- House Weighs Food Safety Bills As Fears Grow
- Abbott Denied Stay In Cordis Stent Spat
- Prioritizing Patents For Stem Cell Inventions
- Alcon Sues Apotex, Sandoz Over Eyedrops Patents
- BSC Accuses SciCo Of Evidence Tampering
- EU To Post Comments On Drug Sector Antitrust Probe
- Zimmer Files Lawsuit Over Bone Screw Patent
- The FTC Pursuit Of Supreme Court Strategy
- Bhopal Case May Be Mediated By Sept. 11 Lawyer
- Biovail Founder Fined $1M In SEC Fraud Suit
- BSC Told To Pay Interest On $19M Medtronic Award
- Indevus, Endo Face Another Class Action Over Merger
- Coughlin Stoia Attys Seek $18M In Celexa Deal Fees
- KCI Vacuum Patents Valid, Uninfringed: Fed. Circ.
- Sonnenschein Nabs Leader, Counsel For FDA Group
- Pfizer To Face Securities Fraud Suit Over Celebrex
- Judge Keeps Alive Dey's Fight For Xopenex ANDA
- FTC, Calif. Launch Reverse Payment Challenge
- Recession-Proofing: IP Is Key
- CVS Assistant Managers Sue For Overtime Pay
- Restoring Science To Its Rightful Place In America
- Genzyme Sued As Gene Therapy Pact Falls Apart
- The Significance Of Takeda V. Mylan
- Regulating Off-Label Info On Drugs, Medical Devices
- Quigley Tries To Bury The Hatchet With Insurers